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Abstract
Back in 2003, we published ‘MAX’ randomization, a process of non-degenerate saturation mutagenesis
using exactly 20 codons (one for each amino acid) or else any required subset of those 20 codons. ‘MAX’
randomization saturates codons located in isolated positions within a protein, as might be required in
enzyme engineering, or else on one face of an α-helix, as in zinc-ﬁnger engineering. Since that time,
we have been asked for an equivalent process that can saturate multiple contiguous codons in a non-
degenerate manner. We have now developed ‘ProxiMAX’ randomization, which does just that: generating
DNA cassettes for saturationmutagenesis without degeneracy or bias. Offering an alternative to trinucleotide
phosphoramidite chemistry, ProxiMAX randomization uses nothing more sophisticated than unmodiﬁed
oligonucleotides and standardmolecular biology reagents. Thus it requires no specialized chemistry, reagents
or equipment, and simply relies on a process of saturation cycling comprising ligation, ampliﬁcation and
digestion for each cycle. The process can encode both unbiased representation of selected amino acids or
else encode them in predeﬁned ratios. Each saturated position can be deﬁned independently of the others.
We demonstrate accurate saturation of up to 11 contiguous codons. As such, ProxiMAX randomization is
particularly relevant to antibody engineering.
Background
Saturation mutagenesis (replacement of wild-type codons
with codons for all 20 amino acids) is a core technique
within the protein engineer’s repertoire. Its importance in
engineering non-native ligand-binding domains is undis-
puted. Thus saturation mutagenesis has played a vital role
in creating synthetic zinc-finger-based transcription factors
[1,2], antibodies and antibody-derived scaffolds [3,4] for
many years, and, more recently, has proved valuable in
engineering modified enzymes [5].
Conventional saturation mutagenesis employs degenerate
codons NNN, NNK or NNS. Although technically
undemanding, degeneracy leads to significant problems that
have provoked a drive for non-degenerate alternatives. Tradi-
tionally, non-degeneracy was achieved by using trinucleotide
phosphoramidites which add whole codons (rather than
single bases) during oligonucleotide synthesis [6]. In 2003,
we described ‘MAX’ randomization [7], which uses standard
oligonucleotides and is useful for enzyme engineering, but
requires separation between randomized codons and thus
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cannot saturate more than two contiguous codons. Recently,
simpler alternatives of ‘small-intelligent libraries’ designed
by the program DC-analyzer [8] and the ‘22c trick’ [9]
have been described, which are optimal methodologies to
saturate small numbers of codons effectively and efficiently,
irrespective of location; although, owing to multiplex PCR
primers, these approaches cannot saturate larger numbers
of codons (see below). In the present paper, we describe
ProxiMAX randomization, which offers all the advantages
of SlonomicsTM [10,11] (an automated, non-degenerate,
enzyme-based process), but can be performed in a standard
molecular biology laboratory. ProxiMAX likewise combines
the benefits of non-degeneracy with the ability to saturate
larger numbers of contiguous codons, a key requirement for
antibody engineering.
Saturation mutagenesis: comparison of
techniques
The advantages and disadvantages of the various approaches
to saturation mutagenesis are compared in Figure 1. The
most critical consequences of degeneracy are the loss of
diversity/functionality [12,13] and inherent encoded bias [7].
Diversity is a measure of the percentage of unique species
within a library. Even the ‘22c trick’ [9] (NDT/VHG/TGG
degeneracy) leads to >60% loss of diversity over 12
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Figure 1 Comparison of performance of common saturation mutagenesis techniques
Green coloration indicates ideal performance, pale pink coloration indicates tolerable performance, and deep pink coloration
indicates unacceptable performance, where non-degenerate methods (a) include ‘small-intelligent libraries’ [8], SlonomicsTM
[10,11] and ProxiMAX. (A) Diversity was calculated using the formula d = 1/(Nkpk2) [12] and is in agreement for
a 12-mer peptide saturated with codon NNN [13]. (B) Ratios represent the theoretical relative concentrations of each
individual gene combining any of the most common codons (leucine/arginine/serine, NNN/NNK; or leucine/valine, 22c
trick) compared with each individual gene containing any combination of the rarest codons (b) [methionine/tryptophan, NNN;
cysteine/aspartate/glutamate/phenylalanine/histidine/isoleucine/lysine/methionine/asparagine/glutamine/tryptophan/
tyrosine, NNK; or 18 codons (omitting leucine/valine), 22c trick]. (C) Truncation is calculated as the percentage of sequences
that contain one or more termination codons within the saturated region. (D) NNN/NNK/trinucleotide oligonucleotides may
be used as a DNA cassette, or as primers in PCR-based mutagenesis; SlonomicsTM and ProxiMAX require a ﬁxed number of
oligonucleotides and the numbers of primers for the 22c trick [9] and small-intelligent libraries [8] were calculated using
the formulae in the respective publications for saturating consecutive codons. (E) cAs dictated by degeneracy limitations.
saturated codons (Figure 1A). It might be argued that
excess screening capacity (e.g. with ribosome or CIS display
[14]) diminishes this issue, but in libraries with more
than three randomized positions, the use of degenerate
codons will probably have a severe impact on the quality
of the output. Since the magnitude of protein–ligand
interactions is a function of both affinity and concentration,
all display screens are based on a pretext of equivalent
concentration of library members. Figure 1(B) demonstrates
that the concentration differences between common and
rare codon combinations are unworkable beyond three
degenerate saturated codons, regardless of methodology.
Library diversity is further restricted by NNK and NNN
saturations which randomly introduce termination codons
(Figure 1C) that may lead to non-functional proteins,
possibly leading to aggregation. Practical issues must also
influencemethod choice.Notwithstanding objections of bias,
the number of primers required to saturate more than three
consecutive codons using either ‘small-intelligent libraries’ or
the ‘22c trick’ are impractical to handlemanually (Figure 1D).
Neither do degenerate methods (including the ‘22c trick’)
allow the potential to exclusively eliminate cysteine, which
is usually undesired in protein and peptide libraries. Finally,
Figure 1(E) compares other desirable attributes of saturation
techniques, including the ability to select codons to suit
the organism of choice, including codon optimization,
ratio-control, subset-selection, etc. Thus we propose that
ProxiMAX is the first technology to offer all desirable
attributes in a manual setting and, as such, will be an
invaluable addition to the protein engineer’s toolbox.
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Figure 2 ProxiMAX methodology
Double-stranded DNA donors, carrying the required ‘MAX’ codons at their termini, are ligated individually on to a
double-stranded DNA acceptor sequence (phosphorylated at the required 5′ end only). The donors can take the form
of partially double-stranded DNA (as shown), fully double-stranded DNA or hairpin oligonucleotides. After ligation, the
products are ampliﬁed, puriﬁed, quantiﬁed and then combined in the required ratios. The combined product is digested with
MlyI. The process is then repeated, using the digestion product from cycle 1 as the acceptor for the next round of ligation.
Different sets of donors are cycled to prevent potential carry-over from one cycle to the next. The inset of the genetic code
shows that any codons may be selected as ‘MAX’ codons, regardless of their sequence.
ProxiMAX randomization: the concept
ProxiMAX randomization is based on iterative cycles of
blunt-ended ligation, amplification and digestion with the
Type IIS restriction endonuclease MlyI. More specifically,
oligonucleotide donors (containing the required codons at
their termini) are ligated on to a conserved acceptor sequence.
Following ligation, the PCR amplification step provides
ample ligated product, while concomitantly diluting non-
ligated contaminants. Subsequent digestion removes all but
the final codon of the donor sequences to generate a new
acceptor,which enters the next cycle (Figure 2). By alternating
different sets of oligonucleotide donors for each cycle, codon
additions can be restricted to a specific saturation cycle.
ProxiMAX development: T4 DNA ligase
exhibits some sequence preference in
blunt-end ligations
To examine process feasibility, preliminary experiments used
a mixture of all 20 donors combined in nominally equal
quantities (based solely on manufacturer’s data). Results
demonstrated that the process worked, but, unsurpris-
ingly, there was bias in the resulting small-scale library
(Supplementary Figure S1 at http://www.biochemsoctrans.
org/bst/041/bst0411189add.htm). Bias might result from
variant oligonucleotide quality, inaccurate estimations of
oligonucleotide concentration, sequence preferences of T4
ligase, amplification bias during PCR or even sequence
preference of the restriction enzyme MlyI. To examine
and/or exclude these factors, ligations and amplifications
were performed in individual parallel reactions. Only after
purification and quantification were the individual amplicons
combined. Analysis at this midpoint in each of six cycles
of saturation (i.e. after combination of individual reactions
and before MlyI digestion) demonstrated that equimolar
mixes (5% of each codon) had been generated successfully
during each cycle of addition (Supplementary Figure S2A
at http://www.biochemsoctrans.org/bst/041/bst0411189add
.htm). However, these data offered no insight as to
whether subsequent ligations would proceed in an equimolar
fashion when those mixtures acted as acceptors. Therefore,
after six cycles of saturation mutagenesis, composition of
the final assembled library was assessed by Roche 454
pyrosequencing, which demonstrated that, whereas most
codons were introduced into the library at the expected
ratio, a few were noticeably over- and under-represented.
In particular, the histidine codon 5′-CAT-3′ was favoured,
whereas codons for lysine and threonine were under-
represented (Supplementary Figure 2B).
By eliminating donor concentration and/or quality and
PCRpreference as potential sources of bias, these data suggest
that T4 DNA ligase exhibits some sequence preference in
blunt-ended ligations, when presented with a mixture of 5′
and 3′ ends, so that, in this substratemixture, the enzymehas a
different reactivity rate for different codons. To examine this
possibility, data from the preceding 6-mer sequence analysis
were studied for expected and observed ratios with respect
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Figure 3 Library construction with controlled codon ratios
(A) DNA sequence analysis of a library encoded by six cycles of codon addition, optimized to provide unbiased representation.
Six cycles of ProxiMAX randomization were undertaken as described in Supplementary Figure S2 (at http://www.
biochemsoctrans.org/bst/041/bst0411189add.htm), using right-handed hairpins (Supplementary Table S3 at
http://www.biochemsoctrans.org/bst/041/bst0411189add.htm) as donors and an amplicon of pUC19 as the acceptor,
with optimized mixtures of 18 codons adjusted to reﬂect the sequence bias illustrated in Supplementary Figure S2(B).
The resulting library was analysed by DNA sequencing, using a MiSeq DNA sequencer according to the manufacturer’s
instructions. Data represent the analysis of 286684 sequences of the correct length, which represented 79.9% of the
entire library. Bars represent the frequency of each codon from each cycle of saturation mutagenesis. The broken line
depicts the target representation for each codon. Further analysis of the library can be found in Supplementary Table S2
(at http://www.biochemsoctrans.org/bst/041/bst0411189add.htm). (B) Schematic representation of the procedure for
assembling a representative 11-mer CDR3 antibody library. Left-hand (LH, six cycles) and right-hand (RH, ﬁve cycles) of
codon additions were performed in parallel as described in Supplementary Figure S2(B) with adjusted ratios of codons to
compensate for sequence preference as determined in Supplementary Figure S2(B). After the ﬁnal MlyI digestions, the two
assemblies were joined together to generate a region of 11 contiguous saturated codons. (C) DNA sequence analysis of the
representative 11-mer CDR3 antibody library. The library was assembled as described in (B) and sequenced using a MiSeq
sequencer according to the manufacturer’s instructions. Data represent the analysis of 461274 sequences of the correct
length, which comprised 74.1% of the entire library. Single codon deletions comprised an additional 7.4% of that library,
whereas double and triple codon deletions comprised 2.0% and 1.2% respectively. Expected (designed) frequencies of each
codon are compared with observed frequencies for locations 95–100e within the CDR3 loop. Further analysis of the library
can be found in Supplementary Table S2.
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to the last base in the phosphate donor/acceptor junction. A
χ 2 statistic with one degree of freedom was calculated for the
16 possible combinations of 3′–5′ preference at the ligation
junction and where P< 0.0001, this was noted (Supple-
mentary Table S1 at http://www.biochemsoctrans.org/
bst/041/bst0411189add.htm). Although there were no
discernible rules for the junction preference directly at the
point of ligation, there are certainly preferences for 3′-T and
5′-C, which supports the observed over-representation for
histidine (CAT), but does not fully explain the reason for
histidine being more preferred than arginine (CGT).
Successful application of ProxiMAX
randomization
To compensate for these apparent sequence preferences, the
six cycles of addition were repeated, with the concentration
of each donor sequence being adjusted during mixing,
to counteract the over- or under-representation shown in
Supplementary Figure S2(B). Thus concentrations of donors
carrying over-represented codons were reduced, whereas
those carrying under-represented codons were increased.
Cysteine and methionine codons were also excluded as these
are deemed to have liabilities in peptide libraries by being
susceptible to oxidation. It is clear from Figure 3(A) that T4
DNA ligase sequence preference can be compensated for by
adjustment of donor concentrations.
Having demonstrated successful equimolar representation,
wenext sought to create amore relevant library fromaprotein
engineering perspective. Saturation of 11 consecutive codons
within the loop of a CDR3 (complementarity-determining
region 3) domain of an antibody VH (variable heavy) chain
domain was undertaken. Each position in the loop required a
separatemixture of codons so that favourable protein-binding
amino acids were included at the correct positions and those
thatwould encode structural ormanufacturing liabilitieswere
excluded. The frequencies of the desired amino acids were
rounded to the nearest 5% in order to simplify mixing of the
codon oligonucleotides and analysis of the final library.
For this longer loop, both right-hand and left-hand
acceptors were employed to build two library components
in parallel (Figure 3B). The 11-mer CDR3 loop was then
assembled by ligating the two fragments. The loop was
sequenced, and remarkable compliancewas achieved between
design specifications (expected) and the actual library
generated (observed; Figure 3C). One notable anomaly was
the arginine codon which was poorly represented in the left-
hand acceptor ligations. This is apparent inFigure 2(C),where
the lack of under-representation of arginine at a particular
addition has led to a compensating over-representation of
other amino acids, for example aspartate at position 95.
Despite this, the majority of codons are remarkably close
to their desired frequency.
Conclusions
Although more involved than conventional degenerate
saturation mutagenesis, we believe that the benefits of
ProxiMAX randomization easily outweigh the increased
outlay on reagents and of time. One to two cycles of
ProxiMAX randomization can be achieved in a day and
thus our exemplar 11-mer library can readily be prepared
in 2 weeks. The bottleneck of directed evolution is library
screening [9] and thus the smaller andmore accurate the initial
library, the greater the efficiency of sampling in selection or
screening and the better the likely outcome. As stated by
Neugebauer and co-workers (Morphosys AG) “The most
critical parameter for all in vitro-based approaches is the
quality of the antibody library” [15]. Thus although the
requirement to perform individual ligations and PCRs may
initially seemunwieldy, performing 20 parallel reactions from
a singlemastermix is not a significant undertaking. The phrase
‘if you want a good result, preparation is nine-tenths of the
work’ was never more apposite.
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Figure S1 Preliminary assessment of ProxiMAX randomization
Individual pairs of complementary oligonucleotides (Table S3; MAXRH1–MAXRH4 and RevRH) were hybridized together, at
10 μM ﬁnal concentration (using the manufacturer’s stated concentrations for each oligonucleotide) and then diluted to a
ﬁnal concentration of 1 μM. These hybridized stocks were then combined to generate equimolar mixtures (R1 pairs for cycle
1 etc.). Then 10 pmol of the R1 mixture was ligated to 3.3 pmol of test acceptor, in a 20 μl reaction volume. The ligation was
diluted 1 in 1000 and duplicate 100 μl PCR ampliﬁcations were performed, using a high-ﬁdelity polymerase (Pfu). The two
PCRs were combined and processed using a QIAquick® PCR puriﬁcation kit (Qiagen). The resulting DNA was resuspended in
30 μl of water and 25 μl of the cleaned product digested using 10 units of fast-digest MlyI (Fermentas) in a 50 μl reaction
volume, which was then heat-inactivated. The process was then repeated using the next set of oligonucleotide donors
and primer (R2 and primer 2 for cycle 2, etc.), except that, at the ligation stage, 5 μl of MlyI-restricted DNA from the
previous cycle (estimated to be ∼3.3 pmol of DNA) replaced the previous acceptor. Two further cycles of saturation (cycles
3 and 4) were performed, using new sets of oligonucleotide donors as primers as indicated in Table S3. The products of
the fourth round of saturation cycling (before MlyI digestion) were inserted into SmaI- and alkaline phosphatase-treated
pUC19 (Fermentas). The histogram represents analysis of inserts contained within 48 resulting clones, where U represents
unreadable codons and X represents non-MAX codons. Ideal 2.4% representation of each codon at each location is indicated
by the broken line (but note that only integer values of cloned codons can be achieved experimentally).
1ProxiMAX randomization is protected by patent numbers EP 1907548, EP 2236612 and US
8357638 B2 ﬁled by Mohammed Ashraf, Marcus Hughes and Anna Hine, and is operated
commercially under the trade name ColibraTM (Isogenica).
2To whom correspondence should be addressed (email a.v.hine@aston.ac.uk).
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Figure S2 Sources of bias in ProxiMAX randomization
The protocol described in Figure S1 was modiﬁed to identify and/or
eliminate potential sources of library bias. To exclude oligonucleotide
concentration differences during annealing, right-handed hairpin donors
were employed (Table S3). To exclude potential T4 DNA ligase
preference for donor sequences and/or ampliﬁcation bias, ligations
and ampliﬁcations were performed in 20 individual parallel reactions.
Individual PCR products were electrophoresed through pre-cast 2%
agarose gels, gel-extracted and quantiﬁed by UV absorbance. They
were then combined in equimolar amounts and the combined product
was digested with MlyI. The digested product was then used as the
acceptor in the subsequent saturation cycle. Six cycles of saturation were
performed usingMAXRH hairpins R1–R3 in sequential succession. (A) DNA
sequence analysis of codon mixing. To determine whether the equimolar
mixing had been achieved, mixtures were sampled midway through
each cycle (i.e. after equimolar combination and before MlyI digestion),
and analysed by Roche 454 pyrosequencing to assess the identity and
proportion of the latest codon addition (each donor should be present at
5% representation). Bars represent the frequency of each codon during
each saturation cycle. (B) DNA sequence analysis of a library encoding
a 6-mer random peptide mixture, made from equimolar mixtures
of codons at each position. To determine the inﬂuence of acceptor
sequence on T4 DNA ligase, the completed library (after six cycles of
randomization) was also analysed by Roche 454 pyrosequencing. Data
represent the analysis of 9074 sequences of the correct length, which
represented 85.1% of the entire library. Bars represent the frequency
of each codon in each saturated position. The broken line depicts the
designed representation of 5% for each codon.
Table S1 Examination of potential sequence preference during
blunt-ended ligations
All unique sequences (8734 of 8874, 98.4%) within the 6-mer library
generated using equimolar mixtures of the 20 donors (Figure S2B) were
analysed for the identity of nucleotides immediately adjacent to the six
ligation points. The observed frequencies (upper value) are noted against
the expected frequencies (lower value; rounded to the nearest integer)
for the 3′–5′ ligation interfaces. Expected frequencies are calculated from
the identities of the 20 selected codons (Supplementary Table 3). The χ2
statistic with one degree of freedom was calculated for the 16 possible
combinations of 3′–5′ preference at the ﬁve ligation junctions. Values
in bold italic are those that have a statistically signiﬁcant difference
between observed and expected frequencies, where P< 0.0001.
5′ position at junction (phosphate donor)
3′ position at junction C G T A
C 57 116 94 88
109 109 109 109
G 511 1199 642 643
873 873 873 873
T 445 1322 829 391
764 764 764 764
A 517 821 462 599
437 437 437 437
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Table S2 Further library analyses
Uncorrected MiSeq data from the libraries illustrated in Figure 2 of the main paper were analysed. Correct length refers to sequences that have both
correct ﬂanking sequences and the correct insert. Errors and diversity are expressed as percentages of sequences that are the correct length. Error
percentages represent an average across all randomized positions.
6-Mer peptide library CDR3 library (11 codons)
Length Correct length (%) 79.9 74.1
Single base additions/deletions (%) 8.0 7.4
Other incorrect length (%) 12.0 18.5
Errors Speciﬁed codons (%) 99.5 99.3
Non-speciﬁed codons (%) 0.4 0.7
Termination codons (%) 0.0 0.1
Diversity Unique sequences (one occurrence) (%) 99.4 99.9
Two occurrences (%) 0.6 0.1
Three or more occurrences (%) 0.0 0.0
Total library sequences 286684 461274
Table S3 Oligonucleotide sequences
‘MAX’ within an oligonucleotide indicates a mixture of independently synthesized oligonucleotides, each containing one of the ‘MAX’
codons [alanine=GCT; cysteine= TGC; aspartate=GAC (right-hand) or GAT (left-hand); glutamate=GAA; phenylalanine= TTC; glycine=GGC;
histidine= CAT; isoleucine=ATC; lysine=AAG; leucine= CTG; methionine=ATG; asparagine=AAC; proline= CCG; glutamine= CAG; arginine= CGT;
serine= TCT; threonine=ACC; valine=GTG; tryptophan= TGG; tyrosine= TAC), whereas ‘MAX(RC)’ represents the reverse complement of each MAX
codon. RevRH may be used as a minimalist reverse complement to the conserved part of all MAXRH primers (Figure 1 of the main paper and
Figure S1) or, alternatively, fully complementary or hairpin oligonucleotides may be substituted in which a (T)4 sequence joins the two strands
(as demonstrated above, in the MAXLH1–3 sequences). Acceptor sequences are fully user-deﬁned. Those employed in Figure S1 (test acceptor)
and the CDR3 randomization experiment are listed. The RH acceptor consists of a mixture of three oligonucleotides in which codons 1, 2 and
3 are TTT, ATC and CAT; TTT, TAC and CCT; and ATG, GTC and CAC respectively. All acceptor sequences were hybridized to fully complementary
oligonucleotides before use. 6-Mer peptide randomizations employed a pUC19 amplicon (primers 5′-phosphateGTAAGATCCTTGAGAGTTTTCGCC-3′
and 5′-CGGTTAGCTCCTTCGGTCCTC -3′) as the acceptor. Underlined regions correspond to PCR primer sequences (where dotted underlines signify the
reverse complement as the primer).
Oligonucleotide Sequence
MAXRH1 5′- GTGCTACGATGTCATTGCGAGTCACGTAMAX-3′
MAXRH2 5′- AGGTAGATCAGTGACACGGAGTCACGTAMAX-3′
MAXRH3 5′- ACAGAACAGGCACTTAGGGAGTCACGTAMAX-3′
MAXRH4 5′-GATCTCACAGTCAGATGGGAGTCACGTAMAX-3′
RevRH 5′-MAX(RC)TACGTGACTC-3′
MAXLH1 5′-MAXTACGTGACTCCCATCTGACTGTGAGATCTTTTGATCTCACAGTCAGATGGGAGTCACGTAMAX(RC)-3′
MAXLH2 5′-MAXTACGTGACTCCGAGATGCTACTGTCGAATTTTTTCGACAGTAGCATCTCGGAGTCACGTAMAX(RC)-3′
MAXLH3 5′-MAXTACGTGACTCGCTCAAGTTACGGTCGATTTTTATCGACCGTAACTTGAGCGAGTCACGTAMAX(RC)-3′
Test acceptor 5′-phosphate-ATCCGATCCTAGTGTATTCTT . . . . . . . . . . . . . . . . . . . . . . .CGCTGTTCTCTGACTGAT-3
′
RH acceptor 5′-phosphateCodon1GACCodon2TGGGGCCAGGGCACCodon3GGTCACCGTCTCCTCAGGTGGAGGCGGTTCAGG
CGGAGGTGGCAGCGGCGGTGGCGGATCGCAGTCTGTGCTGATTGAGCCTGC . . . . . . . . . . . . . . . . . . . . . . .CTCCGTGTCTGCACTTCG-3
′
LH acceptor 5′-CGAAGACCGACAGGGGTAAGACCATCAGTAGTAGGAAAGGTCTCGGCCGTTTCACCATCTCCCGTGACA
ATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGCGTGCCGAGGACACGGCCGTATATTACTGTGCGAGA -3′
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